SCHEMBL21601154

SCHEMBL21601154

Cc1ncc(-c2cnc(OCCOc3ccc(Cl)cc3F)c(F)c2)c(N2CCC(C)(C)CC2)c1CC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.36
▸ PTGER1 P34995 1/20 0.36
▸ S1PR4 O95977 1/20 0.35
▸ EIF4EBP1 Q13541 1/20 0.34
▸ SCN9A Q15858 2/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ S1PR1 P21453 2/20 0.33
▸ PTGDR2 Q9Y5Y4 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MET P08581 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ PPARG P37231 2/20 0.33
▸ PPARD Q03181 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CTSA P10619 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ HTR7 P34969 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21601363 0.95 SCN9A (0.36) CYP2C9PTGER1EIF4EBP1SCN9APTGDR2
SCHEMBL20372553 0.88 KCNH2 (0.42) CYP2C9PTGER1SCN9APTGDR2KCNH2
SCHEMBL21601175 0.86 KCNH2 (0.39) PTGDR2KCNH2FFAR4GRIN2BRAF1
SCHEMBL20372538 0.86 KCNH2 (0.38) CYP2C9PTGER1SCN9APTGDR2LMNA
SCHEMBL20372055 0.86 FFAR4 (0.42) KCNH2FFAR4RAF1BRAF
SCHEMBL20372123 0.85 KCNH2 (0.40) CYP2C9PTGER1SCN9APTGDR2KCNH2
SCHEMBL21601226 0.85 FFAR4 (0.35) KCNH2FFAR4GRIN2BRAF1BRAF
SCHEMBL20372542 0.85 KCNH2 (0.36) SCN9AS1PR1KCNH2FFAR4GRIN2B
SCHEMBL21601404 0.85 KCNH2 (0.39) SCN9AKCNH2FFAR4RAF1BRAF
SCHEMBL21601270 0.85 KCNH2 (0.38) KCNH2FFAR4RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019244066-A2 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2019-12-26 — — WO disclosed
Send feedback